UK Launches World-First £100M AI Biosecurity Lab Backed by £200M from OpenAI and Anthropic
The UK establishes a £100M AI Biosecurity Lab backed by £200M in compute and model credits from OpenAI and Anthropic as part of a £600M AI safety package.
The United Kingdom has launched the worlds first dedicated AI Biosecurity Lab with £100 million in government funding, matched by up to £200 million in compute and trusted model credits from OpenAI and Anthropic. Supported by Google DeepMind and Basecamp Research, the facility anchors a broader £600 million national AI safety and cybersecurity initiative.
£300M Combined Commitment from UK Government, OpenAI, and Anthropic
On October 24, 2026, UK AI Minister Kanishka Narayan announced £100 million in sovereign funding to establish the worlds first dedicated AI Biosecurity Lab. The public investment is amplified by £200 million in private frontier lab commitments: OpenAI pledged up to £100 million in compute, model credits, and trusted access to its specialized life-sciences architectures via its Rosalind Biodefense program, while Anthropic matched with up to £100 million in model credits, trusted model access, and dedicated engineering support.
Google DeepMind Collaboration and Pathogen Countermeasures
Alongside OpenAI and Anthropic, researchers from Google DeepMind and UK life-sciences firm Basecamp Research are partnering with the institution to develop specialized biological foundation models. The labs core mandate centers on early detection of engineered or emerging biological threats and dramatically accelerating the design of vaccines, therapeutics, and medical countermeasures before outbreaks scale.
Anchoring a £600 Million National AI Safety and Cyber Defense Package
The AI Biosecurity Lab serves as the centerpiece of a comprehensive £600 million UK government technology security package ahead of next weeks national Budget. The wider allocation provides £120 million in new funding for the UK AI Security Institute, £130 million to harden national cybersecurity infrastructure using autonomous AI defense tools, and £65 million dedicated specifically to rapid pathogen countermeasure synthesis.